Eric Rose

Eric Rose

Technik-/Wissenschafts-/F&E-Leiter bei MESOBLAST LIMITED

Vermögen: 11 Mio $ am 31.08.2026

75 Jahre
Health Technology
Finance
Commercial Services

Profil

Dr. Eric A. Rose, MD, is an Executive Director & Chief Medical Officer at Mesoblast Ltd., an Executive Vice President-Life Sciences at MacAndrews & Forbes LLC, an Advisor at KBL Healthcare Ventures and a Chairman at LongView Ventures LLC.
He is on the Board of Directors at Orchestra BioMed, Inc. and Mesoblast Ltd. Dr. Rose was previously employed as a Director-Emeritus by Orchestra Biomed Holdings, Inc., a Chairman-Health Evidence & Policy Department by Mount Sinai School of Medicine, an Executive Vice President-Life Sciences by MacAndrews & Forbes Inc., an Independent Director by ABIOMED, Inc., a Chairman by SIGA Technologies, Inc., a Chairman-Surgery Department by Columbia University College of Physicians & Surgeons, a Chairman-Surgery Department by NewYork-Presbyterian Hospital, a Strategic Advisory Board by Broadview Ventures Inc, a Chairman by CircuLite, Inc., a President by International Society for Heart & Lung Transplantation, and a Vice Chairman by VTVX Holdings I LLC.
He also served on the board at National Biodefense Science Board, Keryx Biopharmaceuticals, Inc., Nephros, Inc., Cambrex High Point, Inc. and Nexell Therapeutics, Inc. He received his undergraduate degree from Columbia University College of Physicians & Surgeons and a doctorate degree from Columbia University College of Physicians & Surgeons.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
27.08.2026 6’749’274 ( 0.52% ) 11 Mio $ 31.08.2026

Aktive Positionen von Eric Rose

UnternehmenPositionBeginn
MESOBLAST LIMITED Technik-/Wissenschafts-/F&E-Leiter 01.02.2022
Vorsitzender -
Direktor/Vorstandsmitglied 01.12.2018
Corporate Officer/Principal 01.01.2007
Berater -

Ehemalige bekannte Positionen von Eric Rose

UnternehmenPositionEnde
ORCHESTRA BIOMED HOLDINGS, INC. Direktor/Vorstandsmitglied 03.02.2025
ABIOMED, INC. Direktor/Vorstandsmitglied 22.12.2022
SIGA TECHNOLOGIES, INC. Vorstandsvorsitzender 13.10.2016
Corporate Officer/Principal 01.01.2012
░░░░░░░░ ░░░░░░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Eric Rose im Detail an

Ausbildung von Eric Rose

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

69

Beziehungen ersten Grades

21

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen21

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Distribution Services

International Society for Heart & Lung Transplantation

Commercial Services

Finance

Finance

Health Technology

Consumer Services

Finance

Finance

Consumer Services

National Preparedness & Response Science Board

Health Technology

Health Technology

Finance

Health Technology

-40 %: Die besten Tools exklusiv für Abonnenten - Ihr Schlüssel zu den Top-Investitionen der Zukunft!
T
:
:
PROFITIEREN SIE JETZT